Financial distress is leading to a deluge of restructuring activity and bankruptcy filings. Big pharmaceutical M&A is still in vogue. Energy and pharma M&A also made notable showings. Meanwhile, the new regulatory environment is continuing to unfold through a combination of settlements and actions from the SEC. See our Related Resources for more on the restructuring events, M&A transactions, offerings, and regulations defining today’s business law environment.